Avricore Health Inc.
AVCR.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 110.32% | 99.37% | 58.99% | 16.84% | -21.68% |
| Total Depreciation and Amortization | 26.28% | 46.50% | 78.01% | 131.06% | 221.74% |
| Total Amortization of Deferred Charges | 74.00% | 32.00% | -12.00% | -50.00% | 78.57% |
| Total Other Non-Cash Items | -38.55% | -16.93% | 56.67% | 107.05% | 695.25% |
| Change in Net Operating Assets | -177.36% | -136.96% | 1,753.85% | 260.96% | 276.51% |
| Cash from Operations | 131.26% | 277.90% | 696.94% | 242.39% | 153.19% |
| Capital Expenditure | 53.45% | 51.09% | 39.42% | 16.37% | -38.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -96.18% | -68.46% | -50.36% | -64.04% | -27.18% |
| Cash from Investing | 51.12% | 49.47% | 38.27% | 15.37% | -38.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -73.15% | -93.91% | -88.11% | -83.26% | 120.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -84.98% | -104.97% | -99.74% | -83.32% | 107.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 181.51% | 108.51% | 105.24% | 76.22% | 66.38% |